It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
[Genetic mutation as a risk factor for a patient treated with warfarin].
https://arctichealth.org/en/permalink/ahliterature175913
Source
Duodecim. 2005;121(2):177-80
Publication Type
Article
Date
2005
More detail
Author
Kari Laine
Stefan Lundgren
Matti Ketonen
Author Affiliation
Turun yliopiisto ja TYKS, kliininen farmakologia, Pharmacity, Turku. karlai@utu.fi
Source
Duodecim. 2005;121(2):177-80
Date
2005
Language
Finnish
Publication Type
Article
Keywords
Chest Pain - diagnosis - etiology
Coronary Artery Bypass - methods
Finland
Follow-Up Studies
Hemorrhage - chemically induced - genetics - prevention & control
Humans
Male
Middle Aged
Myocardial Infarction - prevention & control - radiography - surgery
Pharmacogenetics
Point Mutation
Postoperative Complications - chemically induced - prevention & control
Risk assessment
Warfarin - adverse effects - therapeutic use
PubMed ID
15745355
View in PubMed
Less detail
Permalink